We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Microvision
MVIS
$86.7M
| $216K | ﹤0.01% |
59,860
-32,180
| -35% | -$152K |
|
|
VERV
1852
DELISTED
Verve Therapeutics
VERV
| $216K | ﹤0.01% |
6,280
+1,670
| +36% | +$53.3K |
|
1853
Kanzhun
BZ
$7.07B
| $214K | ﹤0.01% |
12,650
+7,500
| +146% | +$169K |
|
1854
First Commonwealth Financial
FCF
$2.17B
| $214K | ﹤0.01% |
16,700
| – | – |
|
|
MODN
1855
DELISTED
MODEL N, INC.
MODN
| $214K | ﹤0.01% |
6,240
+4,000
| +179% | +$116K |
|
|
WE
1856
DELISTED
WeWork Inc.
WE
| $212K | ﹤0.01% |
2,003
+1,981
| +9,005% | +$356K |
|
1857
CAE Inc. Common Shares
CAE
$8.48B
| $211K | ﹤0.01% |
12,604
-100
| -0.8% | -$2.14K |
|
1858
Matsons
MATX
$6.15B
| $210K | ﹤0.01% |
3,413
-2,430
| -42% | -$187K |
|
|
TSE
1859
DELISTED
Trinseo
TSE
| $210K | ﹤0.01% |
11,440
-1,070
| -9% | -$33.5K |
|
1860
Brookdale Senior Living
BKD
$3.67B
| $207K | ﹤0.01% |
48,480
+15,950
| +49% | +$75.6K |
|
1861
Coherus Oncology
CHRS
$224M
| $207K | ﹤0.01% |
21,490
+1,390
| +7% | +$14.1K |
|
1862
iHeartMedia
IHRT
$537M
| $207K | ﹤0.01% |
28,180
| – | – |
|
1863
Koppers
KOP
$966M
| $207K | ﹤0.01% |
9,967
| – | – |
|
1864
Ichor Holdings
ICHR
$2.37B
| $206K | ﹤0.01% |
8,500
| – | – |
|
1865
Zeta Global
ZETA
$5.46B
| $206K | ﹤0.01% |
+31,120
| New | +$192K |
|
1866
A10 Networks
ATEN
$2.25B
| $204K | ﹤0.01% |
15,370
+9,890
| +180% | +$141K |
|
1867
Cerence
CRNC
$366M
| $203K | ﹤0.01% |
12,910
| – | – |
|
1868
Anavex Life Sciences
AVXL
$239M
| $202K | ﹤0.01% |
19,560
| – | – |
|
|
CWEN.A
1869
DELISTED
Clearway Energy Class A
CWEN.A
| $202K | ﹤0.01% |
+6,940
| New | +$236K |
|
1870
PennyMac Financial
PFSI
$4.45B
| $202K | ﹤0.01% |
4,700
+2,980
| +173% | +$156K |
|
1871
Sylvamo
SLVM
$1.55B
| $202K | ﹤0.01% |
+5,970
| New | +$227K |
|
1872
Tencent Music
TME
$15.6B
| $202K | ﹤0.01% |
49,750
| – | – |
|
|
ZUO
1873
DELISTED
Zuora, Inc.
ZUO
| $202K | ﹤0.01% |
27,310
+16,370
| +150% | +$141K |
|
1874
Collegium Pharmaceutical
COLL
$1.17B
| $201K | ﹤0.01% |
12,550
| – | – |
|
1875
America's Car Mart
CRMT
$27.1M
| $201K | ﹤0.01% |
3,300
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.